Researchers found no association between in vitro exposure to SSRI antidepressants and an increased risk of a child developing depression.
Probiotics can support the effects of antidepressants to help relieve symptoms of depression.
A new study will explore how psilocybin affects different networks and serotonin function in the brains of autistic adults.
Ketamine's rapid action as an antidepressant is a result of increasing the activity of a small number of newborn neurons, which are part of ongoing neurogenesis in the brain.
Ketamine's antidepressant effect is a result of the enhancement of Kcnq2 potassium channels in a certain subtype of glutamate-sensitive neurons.
Ketamine treatment leads to an increase in IGF-1, which, in turn, produces an antidepressant effect.
Study reports medications for ADHD have little detectable impact on how much a child with attention deficit hyperactivity disorder learns in the classroom. However, the medications helped children retain attention, improve classroom behavior, and improve seat-time work.
Researchers explore the effect psychedelics have on the brain and how they are effective at treating depression.
A preclinical drug that inhibits the kinase enzyme Cdk5 may have the potential to treat depression, brain injuries, and disorders associated with cognitive impairment.
Using psychiatric medications to treat mental health disorders in children and adolescents does not increase the risk of developing substance use disorders later in life. In fact, pharmacological interventions reduce the risk of developing SUD for those with MDD, ADHD, and psychotic disorders.
Statins reduced negative emotional bias in people with depression. The findings suggest statins may provide protection against depression.
Researchers have identified six predictors that may help determine the correct amount of lithium to treat a patient with bipolar disorder.
